-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US74765K1051 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 160M |
|---|---|
| PE Ratio | None |
| Target Price | 2.5 |
| Beta | 3.08 |
| Dividend Yield | None |
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for QSI using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026